Healthy volunteers help test two forms of experimental drug
NCT ID NCT07071974
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed phase 1 trial enrolled 16 healthy adults to compare two formulations of the drug BI 456906 (Survodutide). Participants received a single injection of each version in random order. Researchers measured how much drug got into the blood and how quickly, to see if the formulations behave similarly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Survodutide (BI 456906)
- What this could lead to
- If successful, this could help select the better formulation for future studies, potentially leading to a more effective or convenient treatment.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It only measures drug levels in the blood, not whether the drug works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test